Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 19

Results For "engineering"

233 News Found

Akron BioProducts and Vor Bio to develop and cGMP manufacture of nucleases
Biotech | March 23, 2022

Akron BioProducts and Vor Bio to develop and cGMP manufacture of nucleases

This collaboration strengthens Akron’s portfolio of off-the-shelf gene-editing technologies while broadening Vor Bio’s collection of nucleases to engineer gene-modified cell therapies


Beghou Consulting strengthens advanced analytics and data science team in Pune
News | March 17, 2022

Beghou Consulting strengthens advanced analytics and data science team in Pune

Since 1993, Beghou Consulting has helped life sciences companies - especially emerging pharmaceutical companies - establish and manage commercial operations to better market and sell therapies


Boston Scientific opens second R&D centre in Pune
News | March 16, 2022

Boston Scientific opens second R&D centre in Pune

The centre will initially employ 170 engineers, bringing the total number of Boston Scientific’s R&D employees in India to more than 300


Indian pharma companies must become the global benchmark of quality: Amit Jaju, Sr. MD, India, Ankura Consulting
interviews | March 13, 2022

Indian pharma companies must become the global benchmark of quality: Amit Jaju, Sr. MD, India, Ankura Consulting

Amit Jaju, Senior Managing Director, India in an interview with Thomas C Thottathil outlined the steps Indian pharma companies should follow to be compliant with global regulatory requirements


Wipro and Pandorum partner to accelerate regenerative medicine with AI
News | March 12, 2022

Wipro and Pandorum partner to accelerate regenerative medicine with AI

Use of Wipro Holmes Artificial Intelligence capabilities will lead to faster development of advanced therapeutics, improving patient outcomes


Novo Nordisk expands research collaboration for biologic medicines
Biotech | March 09, 2022

Novo Nordisk expands research collaboration for biologic medicines

This collaboration has resulted in several high-impact scientific publications describing breakthrough inventions, including the SOMA robotic pill, which has subsequently been licensed exclusively to Novo Nordisk for clinical development


Alkem licenses technology from Harvard to treat ischemic injury and vascular diseases
Biotech | March 03, 2022

Alkem licenses technology from Harvard to treat ischemic injury and vascular diseases

Novel delivery of established growth and neurotrophic factors enables local, sustained release for greater efficacy


Avenge Bio announces peer-reviewed publication on preclinical proof of concept for LOCOcyte platform technology
Biotech | March 03, 2022

Avenge Bio announces peer-reviewed publication on preclinical proof of concept for LOCOcyte platform technology

Ovarian cancer is one of the most difficult cancers to treat. It is typically not detected until later stages, and about 70 percent of patients will have recurrence after an initial treatment, which is often fatal


Medix Biochemica announces expansion of its porfolio
Biotech | March 03, 2022

Medix Biochemica announces expansion of its porfolio

The accelerated growth of Medix Biochemica will establish its status as the ultimate IVD raw materials supplier


Researchers develop a fast, efficient tech to remove pollutants from water
Sustainability | February 28, 2022

Researchers develop a fast, efficient tech to remove pollutants from water

The method shows the removal of seven types of PFAS – even when all of them are found in the same unit of fluid – at a level of efficiency that approaches 90%, and it does so within a few minutes